NeuroXess, a Chinese startup, has made two major breakthroughs in brain-computer interface (BCI) technology, coming to the ...

SHANGHAI, Jan. 2 (Xinhua) -- Chinese startup NeuroXess on Thursday reported two significant clinical-trial milestones: its flexible brain-computer interface (BCI) device successfully decoded the ...

The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) announces new appointments of cancer researchers to lead committees in its expansive scientific program. ECOG-ACRIN is at the forefront of ...

With funding, resources, and collaboration, experts can improve their analysis and help patients. How are ECOG-ACRIN and Caris Life Sciences teaming up to fight cancer? Their recent announcement will ...

The randomized phase 3 trial E3F05 by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) tested whether combined therapy using temozolomide alongside radiation therapy is more effective than ...

Fenske, MD led ECOG-ACRIN EA4151, the first randomized trial to compare treatment with or without stem cell transplant in patients with MRD-negative mantle cell lymphoma in first complete remission.